Why INDP? Indaptus Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
INDP
$2.15+0.01 (+0.47%)
Market ClosedLast close May 4
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products.